117 related articles for article (PubMed ID: 17610610)
1. Fabry disease: case report with emphasis on enzyme replacement therapy and possible future therapeutic options.
Möhrenschlager M; Pontz BF; Lanzl I; Podskarbi T; Henkel V; Ring J
J Dtsch Dermatol Ges; 2007 Jul; 5(7):594-7. PubMed ID: 17610610
[TBL] [Abstract][Full Text] [Related]
2. Fabry disease with aortic regurgitation.
Choi S; Seo H; Park M; Kim J; Hwang S; Kwon K; Her K; Won Y
Ann Thorac Surg; 2009 Feb; 87(2):625-8. PubMed ID: 19161799
[TBL] [Abstract][Full Text] [Related]
3. Amelioration of white-matter lesions in a patient with Fabry disease.
Yamadera M; Yokoe M; Beck G; Mihara M; Oe H; Yamamoto Y; Sakoda S
J Neurol Sci; 2009 Apr; 279(1-2):118-20. PubMed ID: 19185318
[TBL] [Abstract][Full Text] [Related]
4. Enzyme replacement therapy in severe Fabry disease with renal failure: a 1-year follow-up.
Tsambaos D; Chroni E; Manolis A; Monastirli A; Pasmatzi E; Sakkis T; Davlouros P; Goumenos D; Katrivanou A; Georgiou S
Acta Derm Venereol; 2004; 84(5):389-92. PubMed ID: 15370707
[TBL] [Abstract][Full Text] [Related]
5. Angiokeratomas, Fabry disease and enzyme replacement therapy: still a challenge.
Möhrenschlager M; Henkel V; Ring J
Br J Dermatol; 2005 Jan; 152(1):177-8; author reply 178-9. PubMed ID: 15656825
[No Abstract] [Full Text] [Related]
6. Clinical spectrum of Anderson Fabry disease in a Romanian family.
Tudor A; Muşat A; Doscan A; Bari M; Zapucioiu C; Urdea E; Cochior D; Peţa D
Rom J Intern Med; 2006; 44(2):201-10. PubMed ID: 17236300
[TBL] [Abstract][Full Text] [Related]
7. Fabry disease: clinical spectrum and evidence-based enzyme replacement therapy.
Desnick RJ; Banikazemi M
Nephrol Ther; 2006 Jan; 2 Suppl 2():S172-85. PubMed ID: 17373219
[TBL] [Abstract][Full Text] [Related]
8. Fabry disease: clinical features and recent advances in enzyme replacement therapy.
Desnick RJ; Wasserstein MP
Adv Nephrol Necker Hosp; 2001; 31():317-39. PubMed ID: 11692469
[No Abstract] [Full Text] [Related]
9. [Enzyme replacement therapy in Fabry's disease].
Alvarez L; del Pozo C; Trigueros M; Sánchez L; Albero MD; López-Menchero R; Ortega E
Nefrologia; 2005; 25(3):322-7. PubMed ID: 16053014
[TBL] [Abstract][Full Text] [Related]
10. Absence of cornea verticillata in hemizygotes of a novel mutation in fabry disease.
Huerva V; Martín M; Canto LM; Yagüe J
Cornea; 2008 Sep; 27(8):970-2. PubMed ID: 18724168
[TBL] [Abstract][Full Text] [Related]
11. [Two cases of heterozygous Fabry disease].
Shibuya Y; Oku N; Suzuki Y; Gomi T
Nihon Jinzo Gakkai Shi; 2006; 48(5):421-7. PubMed ID: 16913464
[TBL] [Abstract][Full Text] [Related]
12. Fabry disease manifesting as chronic uveitis--treated with enzyme replacement therapy.
Shen YD; Yang CM; Huang JS
Eye (Lond); 2007 Mar; 21(3):431-2. PubMed ID: 16858434
[No Abstract] [Full Text] [Related]
13. Long-term effects of enzyme replacement therapy on fabry cardiomyopathy: evidence for a better outcome with early treatment.
Weidemann F; Niemann M; Breunig F; Herrmann S; Beer M; Störk S; Voelker W; Ertl G; Wanner C; Strotmann J
Circulation; 2009 Feb; 119(4):524-9. PubMed ID: 19153271
[TBL] [Abstract][Full Text] [Related]
14. Recommendations and guidelines for the diagnosis and treatment of Fabry nephropathy in adults.
Ortiz A; Oliveira JP; Wanner C; Brenner BM; Waldek S; Warnock DG
Nat Clin Pract Nephrol; 2008 Jun; 4(6):327-36. PubMed ID: 18431378
[TBL] [Abstract][Full Text] [Related]
15. Fabry disease in a female patient due to a de novo point mutation at position 691 of exon 5.
Brokalaki EI; Hentschke M; Grabbe S; Jansen T
Eur J Med Res; 2006 Jul; 11(7):306-8. PubMed ID: 16899426
[TBL] [Abstract][Full Text] [Related]
16. Kidney transplantation and enzyme alpha-galactosidase A therapy in patient with Fabry disease: a case report.
Dziemianko I; Jezior D; Boratyńska M; Patrzałek D; Kuźniar J; Szyber P; Klinger M
Transplant Proc; 2007 Nov; 39(9):2925-7. PubMed ID: 18022018
[TBL] [Abstract][Full Text] [Related]
17. Angiokeratomas and treatment with enzyme replacement therapy in a patient with Fabry disease.
Merzel Šabović EK; Žerjav Tanšek M; Grošelj U; Dragoš V
Acta Dermatovenerol Alp Pannonica Adriat; 2020 Jun; 29(2):89-91. PubMed ID: 32566958
[TBL] [Abstract][Full Text] [Related]
18. Update on Fabry disease: kidney involvement, renal progression and enzyme replacement therapy.
Breunig F; Wanner C
J Nephrol; 2008; 21(1):32-7. PubMed ID: 18264934
[TBL] [Abstract][Full Text] [Related]
19. Neurological manifestation of Fabry disease--a case report.
Demarin V; Kes VB; Bitunjac M; Ivanković M
Coll Antropol; 2009 Dec; 33 Suppl 2():177-9. PubMed ID: 20120409
[TBL] [Abstract][Full Text] [Related]
20. Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry's cardiomyopathy.
Lui CY; Ju H
Am J Cardiol; 2006 Dec; 98(11):1557-8. PubMed ID: 17126672
[No Abstract] [Full Text] [Related]
[Next] [New Search]
